Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes
We understand that starting a new medication can be daunting, and our team is dedicated to providing guidance and support to manage any potential side effects, such as nausea or gastrointestinal discomfort, ensuring a smooth transition for our patients
Side Effects of Retatrutide A complete safety profile will be confirmed after larger, longer studies
One innovative therapy we offer is the Ozempic shot, a GLP-1 receptor agonist originally developed to manage type 2 diabetes and now widely recognized for its remarkable effectiveness in promoting weight loss
A mixed meal tolerance test demonstrated hypoglycemia, with a glucose level of 49mg/dL (reference range: 7499mg/dL) and hyperinsulinemia of 185.5mU/L (reference range: 3.025.0 mU/L) at the three-hour mark
Medications that act like GLP-1 receptor agonists, such as semaglutide, are designed to mimic the functions of GLP-1 in the body